Keyphrases
High Dose
100%
Methylprednisolone
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
85%
Oral Prednisone
57%
Immunosuppression
28%
3-group
28%
Weight Gain
28%
Long-term Treatment
28%
IV Immunoglobulin
28%
Cushingoid
28%
Quantitative muscle Testing
28%
Adverse Effects
14%
Prednisone
14%
No Significant Difference
14%
Initial Treatment
14%
Disability
14%
Electrophysiologic
14%
In(III)
14%
Cyclosporine
14%
University of Washington
14%
Clinic Visits
14%
St. Louis
14%
Progressive Disability
14%
Inpatient Records
14%
Outpatient Record
14%
Neuromuscular Disease
14%
Enhanced Strength
14%
Frequency of Occurrence
14%
Intravenous Immunoglobulin (IVIg)
14%
Long-term Maintenance Therapy
14%
Retrospective Medical Record Review
14%
Immunosuppressive Medication
14%
Profile Effects
14%
Hand Dynamometer
14%
Medication Profile
14%
Nursing and Health Professions
Drug Megadose
100%
Methylprednisolone
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Polyradiculoneuropathy
85%
Prednisone
71%
Immunoglobulin
42%
Weakness
28%
Long Term Care
28%
Immunosuppressive Treatment
28%
Hospital
14%
Outpatient
14%
Medical Record
14%
Ciclosporin
14%
Dynamometer
14%
Neuromuscular Disease
14%
Maintenance Therapy
14%
Medicine and Dentistry
Drug Megadose
100%
Methylprednisolone
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Polyradiculoneuropathy
85%
Prednisone
71%
Immunoglobulin
42%
Immunosuppressive Treatment
28%
Weakness
28%
Medical Record
14%
Cyclosporine
14%
Outpatient
14%
Maintenance Therapy
14%
Neuromuscular Disease
14%
Adverse Effect
14%
Immunology and Microbiology
Drug Megadose
100%
Methylprednisolone
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Prednisone
71%
Intravenous Immunoglobulin
42%
Immunosuppression
28%
Muscle
28%
Ciclosporin
14%
Medical Record
14%
Pharmacology, Toxicology and Pharmaceutical Science
Methylprednisolone
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Polyradiculoneuropathy
85%
Prednisone
71%
Immunoglobulin
42%
Weakness
28%
Ciclosporin
14%
Neuromuscular Disease
14%
Neuroscience
Polyneuropathy
100%
Methylprednisolone
100%
Prednisone
71%
Intravenous Immunoglobulin
42%
Immunosuppression
28%
Adverse Effect
14%
Ciclosporin
14%
Neuromuscular Disorder
14%